Secondary Logo

Journal Logo

June 2006 - Volume 29 - Issue 3
pp: 217-323


Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer

Das, Prajnan; Skibber, John M.; Rodriguez-Bigas, Miguel A.; More

American Journal of Clinical Oncology. 29(3):219-224, June 2006.

Retrospective Study of Capecitabine and Celecoxib In Metastatic Colorectal Cancer: Potential Benefits and COX-2 as the Common Mediator in Pain, Toxicities and Survival?

Lin, Edward H.; Curley, Steven A.; Crane, Christopher C.; More

American Journal of Clinical Oncology. 29(3):232-239, June 2006.


Phase II NCCTG Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Molina, Julian R.; Jett, James R.; Foster, Nathan; More

American Journal of Clinical Oncology. 29(3):246-251, June 2006.


Phase I-II Study of Pegylated Liposomal Doxorubicin Combined With Weekly Paclitaxel as First-Line Treatment in Patients With Metastatic Breast Cancer

Bourgeois, Hugues; Ferru, Aurélie; Lortholary, Alain; More

American Journal of Clinical Oncology. 29(3):267-275, June 2006.


Head and Neck

Prognostic Factors